UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis

Cell metabolism, 2019-01, Vol.29 (1), p.141-155.e9

2019

Volltextzugriff (PDF)

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube

Cancer discovery, 2016-12, Vol.6 (12), p.1342-1351

2016

Volltextzugriff (PDF)

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Cancer, 2013-01, Vol.119 (2), p.325-331

2013

Volltextzugriff (PDF)

Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series

Gynecologic oncology reports, 2024-06, Vol.53, p.101409, Article 101409

2024

Volltextzugriff (PDF)

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Journal of clinical oncology, 2011-01, Vol.29 (1), p.69-75

2011

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Volltextzugriff (PDF)

Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis

PloS one, 2014-08, Vol.9 (8), p.e104521-e104521

2014

Volltextzugriff (PDF)

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2010-01, Vol.28 (1), p.149-153

2010

Volltextzugriff (PDF)

Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention

Cancer prevention research (Philadelphia, Pa.), 2017-04, Vol.10 (4), p.255-266

2017

Volltextzugriff (PDF)

Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives

JCO oncology practice, 2020-08, Vol.16 (8), p.483-489

2020

Volltextzugriff (PDF)

Phyllodes tumor of the vulva: A case report and literature review highlighting a novel manifestation of Cowden syndrome

Gynecologic oncology reports, 2021-05, Vol.36, p.100752, Article 100752

2021

Volltextzugriff (PDF)

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Cell, 2018-09, Vol.175 (1), p.159-170.e16

2018

Volltextzugriff (PDF)

Identity-related experiences of Asian American trainees in gynecologic oncology

Gynecologic oncology reports, 2022-12, Vol.44, p.101097-101097, Article 101097

2022

Volltextzugriff (PDF)

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

Gynecologic oncology reports, 2020-11, Vol.34, p.100627-100627, Article 100627

2020

Volltextzugriff (PDF)

Nanomedicine for Combination Therapy of Cancer

EBioMedicine, 2015-05, Vol.2 (5), p.366-367

2015

Volltextzugriff (PDF)

Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer

Clinical cancer research, 2004-08, Vol.10 (16), p.5546-5553

2004

Volltextzugriff (PDF)

Assessing gynecologic and breast cancer survivors' sexual health care needs

Cancer, 2011-06, Vol.117 (12), p.2643-2651

2011

Volltextzugriff (PDF)

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Volltextzugriff (PDF)

Superior vena cava syndrome associated with uterine serous carcinoma

Gynecologic oncology reports, 2020-08, Vol.33, p.100593, Article 100593

2020

Volltextzugriff (PDF)

Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome

Gynecologic oncology reports, 2018-08, Vol.25, p.94-97

2018

Volltextzugriff (PDF)

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Contemporary ob/gyn, 2022-04, Vol.67 (4), p.18

2022

Volltextzugriff (PDF)

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.NT-097-NT-097

2019

Volltextzugriff (PDF)

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5899-5899

2017

Volltextzugriff (PDF)

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.TMEM-118-TMEM-118

2017

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Publishing

ThemaOvarian Neoplasms - Pathology

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(61)
Berichte
(4)

Sprache

Englisch
(65)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention

Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives

Phyllodes tumor of the vulva: A case report and literature review highlighting a novel manifestation of Cowden syndrome

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Identity-related experiences of Asian American trainees in gynecologic oncology

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

Nanomedicine for Combination Therapy of Cancer

Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer

Assessing gynecologic and breast cancer survivors' sexual health care needs

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction

Superior vena cava syndrome associated with uterine serous carcinoma

Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Aktive Filter

Suchergebnisse filtern